Advertisement

Index by author

March 01, 1992; Volume 41,Issue 3

A

  1. Arlinghaus, R B

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

B

  1. Boarder, M R

    1. Neuronal "nucleotide" receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP.
      R J Murrin and M R Boarder
      Molecular Pharmacology March 1992, 41 (3) 561-568;

  2. Bonin, H

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

  3. Bouvier, M

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

C

  1. Carrell, H L

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  2. Casazza, J P

    1. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.
      Y P Yun, J P Casazza, D H Sohn, R L Veech and B J Song
      Molecular Pharmacology March 1992, 41 (3) 474-479;

  3. Cheng, Y C

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

  4. Costa, E

    1. Vasoactive intestinal polypeptide facilitates tyrosine hydroxylase induction by cholinergic agonists in bovine adrenal chromaffin cells.
      M Olasmaa, A Guidotti and E Costa
      Molecular Pharmacology March 1992, 41 (3) 456-464;

  5. Costa, T

    1. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
      T Costa, Y Ogino, P J Munson, H O Onaran and D Rodbard
      Molecular Pharmacology March 1992, 41 (3) 549-560;

  6. Curras, M C

    1. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
      M C Curras and R Dingledine
      Molecular Pharmacology March 1992, 41 (3) 520-526;

D

  1. Daly, J W

    1. Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry.
      D G Soergel, T Yasumoto, J W Daly and F Gusovsky
      Molecular Pharmacology March 1992, 41 (3) 487-493;

  2. Dickel, C

    1. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors.
      C Schwanstecher, C Dickel and U Panten
      Molecular Pharmacology March 1992, 41 (3) 480-486;

  3. Dilella, A G

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

  4. Dingledine, R

    1. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
      M C Curras and R Dingledine
      Molecular Pharmacology March 1992, 41 (3) 520-526;

  5. Duax, W L

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  6. Dutschman, G E

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

E

  1. Elshourbagy, N A

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

F

  1. Farquhar, D

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  2. Flocco, M M

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  3. Frielle, T

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

G

  1. Glusker, J P

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  2. Goldmann, S

    1. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
      W Zheng, J Stoltefuss, S Goldmann and D J Triggle
      Molecular Pharmacology March 1992, 41 (3) 535-541;

  3. Gommeren, W

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

  4. Griffin, J F

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  5. Guidotti, A

    1. Vasoactive intestinal polypeptide facilitates tyrosine hydroxylase induction by cholinergic agonists in bovine adrenal chromaffin cells.
      M Olasmaa, A Guidotti and E Costa
      Molecular Pharmacology March 1992, 41 (3) 456-464;

  6. Gusovsky, F

    1. Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry.
      D G Soergel, T Yasumoto, J W Daly and F Gusovsky
      Molecular Pharmacology March 1992, 41 (3) 487-493;

H

  1. Harbon, S

    1. Activation of beta-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event.
      L D Khac, A Mokhtari, M Renner and S Harbon
      Molecular Pharmacology March 1992, 41 (3) 509-519;

  2. Hijioka, T

    1. Kupffer cells contain voltage-dependent calcium channels.
      T Hijioka, R L Rosenberg, J J Lemasters and R G Thurman
      Molecular Pharmacology March 1992, 41 (3) 435-440;

I

  1. Im, G J

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

  2. Ivins, J K

    1. Competitive regulation of phospholipase C responses by cAMP and calcium.
      J B Schachter, J K Ivins, R N Pittman and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 577-586;

J

  1. Janssen, P A

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

  2. Janssen, P M

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

K

  1. Khac, L D

    1. Activation of beta-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event.
      L D Khac, A Mokhtari, M Renner and S Harbon
      Molecular Pharmacology March 1992, 41 (3) 509-519;

  2. Khan, S

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  3. Korman, D R

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

  4. Kumar, C S

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

L

  1. Lee, J A

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

  2. Lemasters, J J

    1. Kupffer cells contain voltage-dependent calcium channels.
      T Hijioka, R L Rosenberg, J J Lemasters and R G Thurman
      Molecular Pharmacology March 1992, 41 (3) 435-440;

  3. Leysen, J E

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

M

  1. Mather, R J

    1. Intracellular guanosine-5'-O-(2-thiodiphosphate) alters the dynamics of receptor-mediated responses in bullfrog sympathetic neurons.
      M A Simmons and R J Mather
      Molecular Pharmacology March 1992, 41 (3) 527-534;

  2. Mellors, J W

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

  3. Mokhtari, A

    1. Activation of beta-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event.
      L D Khac, A Mokhtari, M Renner and S Harbon
      Molecular Pharmacology March 1992, 41 (3) 509-519;

  4. Munson, P J

    1. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
      T Costa, Y Ogino, P J Munson, H O Onaran and D Rodbard
      Molecular Pharmacology March 1992, 41 (3) 549-560;

  5. Murrin, R J

    1. Neuronal "nucleotide" receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP.
      R J Murrin and M R Boarder
      Molecular Pharmacology March 1992, 41 (3) 561-568;

N

  1. Nantel, F

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

  2. Nehete, P N

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  3. Nguyen, C T

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

  4. Nowak, B J

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  5. Nuthalaganti, P

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

O

  1. Ogino, Y

    1. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
      T Costa, Y Ogino, P J Munson, H O Onaran and D Rodbard
      Molecular Pharmacology March 1992, 41 (3) 549-560;

  2. Olasmaa, M

    1. Vasoactive intestinal polypeptide facilitates tyrosine hydroxylase induction by cholinergic agonists in bovine adrenal chromaffin cells.
      M Olasmaa, A Guidotti and E Costa
      Molecular Pharmacology March 1992, 41 (3) 456-464;

  3. Onaran, H O

    1. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
      T Costa, Y Ogino, P J Munson, H O Onaran and D Rodbard
      Molecular Pharmacology March 1992, 41 (3) 549-560;

P

  1. Panten, U

    1. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors.
      C Schwanstecher, C Dickel and U Panten
      Molecular Pharmacology March 1992, 41 (3) 480-486;

  2. Pauwels, P J

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

  3. Pittman, R N

    1. Competitive regulation of phospholipase C responses by cAMP and calcium.
      J B Schachter, J K Ivins, R N Pittman and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 577-586;

  4. Plunkett, W

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  5. Punzi, J S

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

R

  1. Reisine, T

    1. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells.
      M Tallent and T Reisine
      Molecular Pharmacology March 1992, 41 (3) 452-455;

  2. Renner, M

    1. Activation of beta-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event.
      L D Khac, A Mokhtari, M Renner and S Harbon
      Molecular Pharmacology March 1992, 41 (3) 509-519;

  3. Rodbard, D

    1. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
      T Costa, Y Ogino, P J Munson, H O Onaran and D Rodbard
      Molecular Pharmacology March 1992, 41 (3) 549-560;

  4. Rosenberg, R L

    1. Kupffer cells contain voltage-dependent calcium channels.
      T Hijioka, R L Rosenberg, J J Lemasters and R G Thurman
      Molecular Pharmacology March 1992, 41 (3) 435-440;

S

  1. Sastry, J K

    1. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
      J K Sastry, P N Nehete, S Khan, B J Nowak, W Plunkett, R B Arlinghaus and D Farquhar
      Molecular Pharmacology March 1992, 41 (3) 441-445;

  2. Schachter, J B

    1. Competitive regulation of phospholipase C responses by cAMP and calcium.
      J B Schachter, J K Ivins, R N Pittman and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 577-586;
    2. Cyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell line.
      J B Schachter and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 587-597;

  3. Schwanstecher, C

    1. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors.
      C Schwanstecher, C Dickel and U Panten
      Molecular Pharmacology March 1992, 41 (3) 480-486;

  4. Simmons, M A

    1. Intracellular guanosine-5'-O-(2-thiodiphosphate) alters the dynamics of receptor-mediated responses in bullfrog sympathetic neurons.
      M A Simmons and R J Mather
      Molecular Pharmacology March 1992, 41 (3) 527-534;

  5. Soergel, D G

    1. Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry.
      D G Soergel, T Yasumoto, J W Daly and F Gusovsky
      Molecular Pharmacology March 1992, 41 (3) 487-493;

  6. Sohn, D H

    1. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.
      Y P Yun, J P Casazza, D H Sohn, R L Veech and B J Song
      Molecular Pharmacology March 1992, 41 (3) 474-479;

  7. Song, B J

    1. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.
      Y P Yun, J P Casazza, D H Sohn, R L Veech and B J Song
      Molecular Pharmacology March 1992, 41 (3) 474-479;

  8. Stoltefuss, J

    1. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
      W Zheng, J Stoltefuss, S Goldmann and D J Triggle
      Molecular Pharmacology March 1992, 41 (3) 535-541;

  9. Strong, P

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  10. Sutiphong, J A

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

  11. Suzuki, T

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

  12. Sylvester, D R

    1. Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum.
      N A Elshourbagy, J A Lee, D R Korman, P Nuthalaganti, D R Sylvester, A G Dilella, J A Sutiphong and C S Kumar
      Molecular Pharmacology March 1992, 41 (3) 465-473;

T

  1. Tallent, M

    1. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells.
      M Tallent and T Reisine
      Molecular Pharmacology March 1992, 41 (3) 452-455;

  2. Tew, K D

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  3. Thurman, R G

    1. Kupffer cells contain voltage-dependent calcium channels.
      T Hijioka, R L Rosenberg, J J Lemasters and R G Thurman
      Molecular Pharmacology March 1992, 41 (3) 435-440;

  4. Tramontano, E

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

  5. Triggle, D J

    1. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
      W Zheng, J Stoltefuss, S Goldmann and D J Triggle
      Molecular Pharmacology March 1992, 41 (3) 535-541;

V

  1. Valiquette, M

    1. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
      T Suzuki, C T Nguyen, F Nantel, H Bonin, M Valiquette, T Frielle and M Bouvier
      Molecular Pharmacology March 1992, 41 (3) 542-548;

  2. Veech, R L

    1. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.
      Y P Yun, J P Casazza, D H Sohn, R L Veech and B J Song
      Molecular Pharmacology March 1992, 41 (3) 474-479;

W

  1. Winkler, S R

    1. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
      J W Mellors, G E Dutschman, G J Im, E Tramontano, S R Winkler and Y C Cheng
      Molecular Pharmacology March 1992, 41 (3) 446-451;

  2. Wolfe, B B

    1. Competitive regulation of phospholipase C responses by cAMP and calcium.
      J B Schachter, J K Ivins, R N Pittman and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 577-586;
    2. Cyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell line.
      J B Schachter and B B Wolfe
      Molecular Pharmacology March 1992, 41 (3) 587-597;

  3. Wynants, J

    1. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
      J E Leysen, P M Janssen, W Gommeren, J Wynants, P J Pauwels and P A Janssen
      Molecular Pharmacology March 1992, 41 (3) 494-508;

Y

  1. Yasumoto, T

    1. Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry.
      D G Soergel, T Yasumoto, J W Daly and F Gusovsky
      Molecular Pharmacology March 1992, 41 (3) 487-493;

  2. Yun, Y P

    1. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.
      Y P Yun, J P Casazza, D H Sohn, R L Veech and B J Song
      Molecular Pharmacology March 1992, 41 (3) 474-479;

Z

  1. Zacharias, D E

    1. Molecular conformation of estramustine and two analogues.
      J S Punzi, W L Duax, P Strong, J F Griffin, M M Flocco, D E Zacharias, H L Carrell, K D Tew and J P Glusker
      Molecular Pharmacology March 1992, 41 (3) 569-576;

  2. Zheng, W

    1. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
      W Zheng, J Stoltefuss, S Goldmann and D J Triggle
      Molecular Pharmacology March 1992, 41 (3) 535-541;
Back to top

In this issue